WO2023111877 - A STABLE EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE
National phase entry:
Publication Number
WO/2023/111877
Publication Date
22.06.2023
International Application No.
PCT/IB2022/062183
International Filing Date
14.12.2022
Title **
[English]
A STABLE EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE
[French]
COMPOSITION PHARMACEUTIQUE STABLE À LIBÉRATION PROLONGÉE DE CLOZAPINE
Applicants **
INTAS PHARMACEUTICALS LTD.
Inventors
PATEL, Rikin
PANDYA, Kavan
KANSAGRA, Piyush
DHAVALE, Satyavan
SEHGAL, Ashish
Priority Data
202121058299
15.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1956 | |
| EPO | Filing, Examination, Granting | 11576 | |
| Japan | Filing, Examination, Granting | 1938 | |
| South Korea | Filing, Examination, Granting | 1672 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,882
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides to a stable extended release pharmaceutical composition of Clozapine and processes for preparation thereof, wherein the said pharmaceutical composition provides improved stability.[French]
La présente invention concerne une composition pharmaceutique stable à libération prolongée de Clozapine et des procédés de préparation de celle-ci, ladite composition pharmaceutique présentant une stabilité améliorée.